Ranibizumab Effective for Pigment Epithelial Detachment

Low-dose ranibizumab is effective in treating pigment epithelial detachment in patients with neovascular age-related macular degeneration, a post hoc analysis of the HARBOR study suggests.
Medscape Medical News

Full Story →